Log In
Print
BCIQ
Print
Print this Print this
 

ADC-1013

  Manage Alerts
Collapse Summary General Information
Company Alligator Bioscience AB
DescriptionAntibody-based CD40 receptor activator immunotherapy
Molecular Target CD40
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today